Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Coloplast Director's Dealing 2019

Aug 27, 2019

3358_rns_2019-08-27_d1f9f7f8-7edf-4ac1-bacb-1b6e5b81c349.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Coloplast

Ostomy Care

Continence Care

Wound & Skin Care

Interventional Urology

Nasdaq Copenhagen

27 August 2019

Coloplast A/S

Holtedam 1

3050 Humlebæk

Denmark

Tlf: +45 4911 1111

www.coloplast.com

CVR-nr. 69749917

Report on transactions of executives and related parties in Coloplast shares and related securities

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.

The below transaction concerns the exercise of share options (purchase) and sale of shares.

Calculation of share price:

When calculating the share price in connection with exercise of share options the purchase price is based on the strike price. The strike price is the share price at the grant date. In connection with sales the share price on the time of exercise is used.

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Paul R. Marcun
2 Reason for the notification
a) Position/status Executive Vice President
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Coloplast A/S (CVR-no.: 69749917)
b) LEI 529900NN7SOJ5QG82X67
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code Share options
ISIN: DK0060448595
b) Nature of the transaction Exercise of share options (purchase)
c) Price(s) and volume(s) Price(s) Volumes(s)
482.67 12,282
d) Aggregated information
- Aggregated volume
- Price 12,282 shares
DKK 482.67
e) Date of the transaction 2019-08-23, 09:12 UTC
f) Place of the transaction Outside a trading venue

This information is available in Danish and in English, in case of doubt the Danish version prevails. For further information: Anne-Sofie Søegaard, tel.: +45 4911 1924


Coloplast

Ostomy Care

Continence Care

Wound & Skin Care

Interventional Urology

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Paul R. Marcun
2 Reason for the notification
a) Position/status Executive Vice President
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Coloplast A/S (CVR-no.: 69749917)
b) LEI 529900NN7SOJ5QG82X67
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument B shares
Identification code ISIN: DK0060448595
b) Nature of the transaction Sale of shares
c) Price(s) and volume(s) Price(s) Volumes(s)
810.75 12,282
d) Aggregated information
- Aggregated volume 12,282 shares
- Price 810.75 DKK
e) Date of the transaction 2019-08-26, 15:00 UTC
f) Place of the transaction Outside a trading venue